Discover Opportunities months before the RFP drops
Learn more →Retrieving contract details... Hang tight!
See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
Premium
Clean & enrich your CRM automatically
Premium
Get complete source documentation & analysis
This contract includes 1 purchase order from Sep 16, 2024 to Sep 16, 2024
| Buyer | Vendor | Issued Date | Quantity |
|---|---|---|---|
| NIH NCI | BOSTON CELL STANDARDS INC. | Sep 16, 2024 | 1 |
Full Purchase Intelligence Available
Get complete pricing, descriptions, and financial details for all 1 purchase orders
Unlock Full Details →See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
No public files available for this contract.
Contract documentation may be available through official government sources or agency portals. Starbridge can help you track down and retrieve these files.
TOPIC 428 - NCI SBIR TRANSITION TO PHASE II SOLICITATION FY 2023
Effective Date
Aug 15, 2023
Expires
Effective: Aug 15, 2023
Expires:
TOPIC 428 - NCI SBIR TRANSITION TO PHASE II SOLICITATION FY 2023
ActivePURPOSE: TO PROVIDE CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS.
Effective Date
Jul 1, 2021
Expires
Effective: Jul 1, 2021
Expires:
PURPOSE: TO PROVIDE CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS.
ActiveSBIR FY25 CONCEPT AWARD: DEVELOPMENT OF ENGINEERED TRNA THERAPEUTICS FOR CLEAR CELL RENAL CELL CARCINOMA
Effective Date
Sep 15, 2025
Expires
Effective: Sep 15, 2025
Expires:
SBIR FY25 CONCEPT AWARD: DEVELOPMENT OF ENGINEERED TRNA THERAPEUTICS FOR CLEAR CELL RENAL CELL CARCINOMA
ActiveSBIR PHASE II, TOPIC 429: A NEW PARADIGM FOR AUTOLOGOUS AND ALLOGENEIC CELL THERAPY MANUFACTURING
Effective Date
Sep 15, 2023
Expires
Effective: Sep 15, 2023
Expires:
SBIR PHASE II, TOPIC 429: A NEW PARADIGM FOR AUTOLOGOUS AND ALLOGENEIC CELL THERAPY MANUFACTURING
ActiveSee who's winning contracts, track spending trends, and identify your best opportunities before your competition.
Schedule Your Demo →Premium
Clean & enrich your CRM automatically
Premium
Get complete source documentation & analysis